期刊文献+

外源性表皮生长因子对口腔鳞癌细胞系尿激酶型纤溶酶原激活剂及其抑制剂活性的影响

Epidermal growth factor differently modulate activity of urokinase plasminogen activator and plasminogen ac-tivator inhibitor-1 in oral squamous cell carcinoma and metastasis carcinoma cell lines
原文传递
导出
摘要 目的:探讨表皮生长因子(Epidermal growth factor,EGF)和口腔鳞癌侵袭转移的关系。方法:采用发色底物反应法测量不同浓度EGF作用于口腔鳞癌TSCCa细胞系及颈淋巴转移癌GNM细胞系后u-PA和PAI-1的活性,同时用Boyden Chamber观察EGF诱导口腔鳞癌TSCCa和GNM细胞转移作用。结果:不同浓度的EGF(0ng/ml,10ng/ml,20ng/ml,40ng/ml,80ng/ml)作用于两种细胞系后,随着外源性EGF浓度的增加,GNM和TSCCa细胞中u-PA和PAI-1的活性均有增加,与对照组相比差异有显著性(p<0.05);而以TSCCa细胞中u-PA和PAI-1的活性增加较为明显,u-PA和PAI-1活性与外源性EGF有剂量依赖关系,用不同浓度10ng/ml,20ng/ml,40ng/ml,80ng/ml的EGF培养TSCCa和GNM细胞2h,GNM和TSCCa细胞穿过滤膜数均有增加,在相同的浓度内,TSCCa细胞较GNM细胞增加较为明显,两者相比差异有显著性(p<0.05)。结论:EGF可促进口腔鳞癌细胞侵袭转移。 Objective: To detect the role of epidermal growth factor (EGF) on the invasiveness and metastasis of human oral squamous cell carcinoma. Method: Using chromogenic substrate assay to determine the activity of u-PA and PAI-1 in oral squamous cell carcinoma cell lines TSCCa and metastasis carcinoma cell lines GNM treated by different levels of EGF. Boyder chamber were used to observe the function of metastasis in oral squamous cell carcinoma cells TSCCa and GNM. Result: The different levels of EGF (0 ng/ml, 10 ng/ml, 20 ng/ml, 40 ng/ml, 80 ng/ml) had increased the activity of u-PA and PAI-lin TSCCa and GNM cell lines, Moreover, the activity of u-PA and PAI-1 had more dependent on EGF. The cells in lower chamber were increased after cultured for 2 hours by different levels of EGF,which were remarked higher in TSCCa cell lines than that of in GNM cell lines (P〈0.05). Conclusion: EGF may be a factor associated with invasive and metastasis potential of oral squamous cell carcinoma.
出处 《临床口腔医学杂志》 2009年第4期201-203,共3页 Journal of Clinical Stomatology
关键词 表皮生长因子 口腔鳞癌 肿瘤转移 纤溶酶原激活剂 纤溶酶原激活剂抑制剂 epidermal growth factor oral carcinoma tumor metastasis plasminogen activator plasminogen activator inhibitor- 1
  • 相关文献

参考文献9

  • 1Bussolino F, Mantovani A, Persico G. Molecular mechanisms of blood vessel formation [J]. TIBS, 1997,22 (3) : 251-260.
  • 2Tsujimo H,Yura Y,Yoshika Y,et al. Effect of epider growth factor adiministration on the development of mouse salivary gland carcinoma[J]. J Oral Pathol Med, 1999, 28: 30-36.
  • 3金晓明,李金荣,李雅馨,李祖兵.人口腔鳞癌裸鼠移植瘤中u-PA系统的表达及意义[J].现代口腔医学杂志,2002,16(3):197-199. 被引量:2
  • 4Sumiyoshi K, Baba S,Sakaguchi,et al. Increase in levels of plasminogen activator and type-1 plasminogen activator inhibitor in human breast cancer: possible roles in tumor progression and metastasis [J]. Thromb Res, 1991,63: 159-168.
  • 5高进.癌的侵袭与转移[M].北京:北京医科大学中国协和医科大学联合出版社,1996.64-150.
  • 6Yasude T,Sakata Y, Kitamura K,et al. localization of plasminogen activator and their inhibitors in squamous cell crcinomas of the head and neck[J]. Head Neck, 1997, 19:611-616.
  • 7Dear AE, Mecleal FRL. The cellular and molecular biology of plasminogen activator inhibitor type -2 [J]. Fibrinolysis, 1995,9: 321 - 330.
  • 8Tong WM,Eillnger A, Shinin Y,et al. Epidermal growth factor receptor expression in primary cultured human colorecetal carcinoma cells[J]. Br J Cancer, 1998,77: 1792-1798.
  • 9Etience MC,Plvot X, Formento JL, et al. A multifactorial approach including tumoral epidermal growth factor receptor, p53, thymidycate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-Fluomuracil [J]. Br J Cancer, 1999, 79: 1664-1669.

二级参考文献9

  • 1Boucher C,Spyratos F,Matrin PM,et al.Prognostic value of urokinase-type plasminogen activator(u-PA) and plasminogen activator inhibitor PAI-1 and PAI-2 in breast carcinoma.Br J Cancer,1994,69:398.
  • 2Oka T,Teruyoshi I,Toyohiko N,et al.Immunohistochemical evidence of urokinase-type plasminogen activator in primary and metastatic of pulmonary adenocarcinoma.Cancer Res,1991,51:3522.
  • 3Yonemura Y,Nojima N,Kaji M,et al.E-cadherin and urokinase-type plasminogen activator tissue status in gastric carcinoma,Cancer,1995,51:3522.
  • 4Duggan C,Kennedy S,Kramer MD,et al.Plasminogen activator inhibitor type 2 in breast cancer.Br J Cancer,1997,76:622.
  • 5Holst-Hansen C,Johannessen B,Hoyer-hansen G,et al.Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiness.Clin Exp Metastasis,1996,14:297.
  • 6De varis TJ,van Muijen GN,Ruiter DJ.The plasminogen activation system in tumor invasion and metastasis.Pathol Res Pract,1996,192:718.
  • 7Tsuboi R,Rifkin DB.Bimodal relationship between invasion of the amniotic membrane and plasminogen activity.Int J Cancer,1990,46:56.
  • 8Pyke C,Ralfkiaer E,Ronne E,et al.Immunohistochemical detection of the receptor of urokinase plasminogen activator in human colon cancer.Histopathology,1994,24:131.
  • 9金辉喜,李金荣.田基黄对舌癌细胞株TSCCa裸鼠移植瘤抑制作用的研究[J].口腔医学纵横,1997,13(3):131-133. 被引量:11

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部